The origin of brain malignancies at the blood-brain barrier

被引:9
|
作者
Mcdonald, Brennan [1 ]
Barth, Kathrin [1 ]
Schmidt, Mirko H. H. [1 ]
机构
[1] Tech Univ Dresden, Inst Anat, Med Fac Carl Gustav Carus, Sch Med, Dresden, Germany
关键词
Cancer; Brain metastasis; Tumor microenvironment; Organotropism; Pre-metastatic niche; Metastatic niche; Circulating tumor cells; Neurovascular unit; Extracellular matrix; CELL LUNG-CANCER; ANTI-ANGIOGENIC THERAPIES; GLIOBLASTOMA STEM-CELLS; NEGATIVE BREAST-CANCER; E-SELECTIN LIGANDS; GROWTH-FACTOR; MATRIX METALLOPROTEINASES; METASTATIC NICHE; CO-OPTION; IN-VIVO;
D O I
10.1007/s00018-023-04934-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite improvements in extracranial therapy, survival rate for patients suffering from brain metastases remains very poor. This is coupled with the incidence of brain metastases continuing to rise. In this review, we focus on core contributions of the blood-brain barrier to the origin of brain metastases. We first provide an overview of the structure and function of the blood-brain barrier under physiological conditions. Next, we discuss the emerging idea of a pre-metastatic niche, namely that secreted factors and extracellular vesicles from a primary tumor site are able to travel through the circulation and prime the neurovasculature for metastatic invasion. We then consider the neurotropic mechanisms that circulating tumor cells possess or develop that facilitate disruption of the blood-brain barrier and survival in the brain's parenchyma. Finally, we compare and contrast brain metastases at the blood-brain barrier to the primary brain tumor, glioma, examining the process of vessel co-option that favors the survival and outgrowth of brain malignancies.
引用
收藏
页数:27
相关论文
共 50 条
  • [1] The origin of brain malignancies at the blood–brain barrier
    Brennan McDonald
    Kathrin Barth
    Mirko H. H. Schmidt
    Cellular and Molecular Life Sciences, 2023, 80
  • [2] The blood-brain barrier and blood-tumour barrier in brain tumours and metastases
    Arvanitis, Costas D.
    Ferraro, Gino B.
    Jain, Rakesh K.
    NATURE REVIEWS CANCER, 2020, 20 (01) : 26 - 41
  • [3] The Blood-Brain Barrier
    Daneman, Richard
    Prat, Alexandre
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2015, 7 (01):
  • [4] Blood-brain barrier Part III: Therapeutic approaches to cross the blood-brain barrier and target the brain
    Weiss, N.
    Miller, F.
    Cazaubon, S.
    Couraud, P. -O.
    REVUE NEUROLOGIQUE, 2010, 166 (03) : 284 - 288
  • [5] Blood-Brain Barrier and Traumatic Brain Injury
    Alves, Jose Luis
    JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (02) : 141 - 147
  • [6] Heterogeneity of the blood-brain barrier
    Wilhelm, Imola
    Nyul-Toth, Adam
    Suciu, Maria
    Hermenean, Anca
    Krizbai, Istvan A.
    TISSUE BARRIERS, 2016, 4 (01):
  • [7] The Blood-Brain Barrier in Psychoneuroimmunology
    Banks, William A.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2009, 29 (02) : 223 - +
  • [8] The dynamic blood-brain barrier
    Keaney, James
    Campbell, Matthew
    FEBS JOURNAL, 2015, 282 (21) : 4067 - 4079
  • [9] Perlecan and the blood-brain barrier: beneficial proteolysis?
    Roberts, Jill
    Kahle, Michael P.
    Bix, Gregory J.
    FRONTIERS IN PHARMACOLOGY, 2012, 3
  • [10] Neurological diseases in relation to the blood-brain barrier
    Rosenberg, Gary A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 (07) : 1139 - 1151